Wangen C, Raithel A, Tillmanns J, Gege C, et al. Validation of nuclear receptor RORgamma isoform 1 as a novel host-directed antiviral target based on the modulation of cholesterol levels. Antiviral Res 2023 Dec 4:105769. doi: 10.1016/j.antiviral.2023.105769.
PMID: 38056603